Fundz

Palvella Therapeutics, Inc. reported raising $4.44 Million in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEJun 14, 2018$4.4M of $5M raised

Amount Raised

$4.44 Million

$4.44 Million sold, per SEC Form D (first sale Jun 14, 2018)

Round Type

Seed

WayneBiotechnology

Quick answer

Palvella Therapeutics raised $4.44 Million in a Seed round, dated June 14, 2018. Palvella Therapeutics is based in Wayne, Pennsylvania, United States.

How much did Palvella Therapeutics raise?
Palvella Therapeutics raised $4.44 Million in a Seed round on June 14, 2018.
What does Palvella Therapeutics do?
Palvella Therapeutics (NASDAQ: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which..
Where is Palvella Therapeutics based and how big is it?
Palvella Therapeutics is based in Wayne, Pennsylvania, United States. Fundz records about 30 employees.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Palvella Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • XyloCor Therapeutics, Inc. raised $200K (Pre-Seed) on July 26, 2018.
  • Vektor Medical raised $11K (Pre-Seed) on July 26, 2018.
  • BehaVR raised $500K (Seed) on July 25, 2018.
  • Marina Biotech, Inc. raised $1.5M (Seed) on July 25, 2018.
  • Auron Therapeutics raised $27M on July 25, 2018.
  • Windtree Therapeutics raised $1.5M (Seed) on July 25, 2018.

Who to call at Palvella Therapeutics, and when

A new round usually means Palvella Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Palvella Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Palvella Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Palvella Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Palvella Therapeutics

Location

125 STRAFFORD AVENUE

Wayne, Pennsylvania, United States

About

Palvella Therapeutics (NASDAQ: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. The Company is developing a broad pipeline of product candidates based on its patented QTORIN™ platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Its lead product candidate, QTORIN 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Palvella Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Palvella Therapeutics's next move

See what Strategic adds

Palvella Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.